IGF-1 LR3 1MG

IGF-1 LR3 1MG

$148.00

For Research Use Only — Not for Human or Veterinary Consumption. Sold by Longevra Research LLC for laboratory use only. Not approved by the FDA. Not intended to diagnose, treat, cure, prevent, or mitigate any disease.

IGF-1 LR3 is a modified version of insulin-like growth factor 1. The natural protein is 70 amino acids; the LR3 version adds a 13-amino-acid extension at the N-terminus and substitutes arginine for glutamic acid at position 3. Both modifications reduce its binding to IGF-binding proteins, which extends its half-life in cell-culture media. That’s the practical reason researchers use it instead of native IGF-1.

What ships: 1MG per vial · ≥99% HPLC-verified purity · MS-confirmed identity · batch-specific Certificate of Analysis.

Bulk pricing — auto-applied at checkout
QuantityYou savePer unit
3+5%$140.60
5+10%$133.20
10+15%$125.80

Description

IGF-1 LR3 is a recombinant analog of human insulin-like growth factor 1 (IGF-1) carrying two modifications: an N-terminal 13-amino-acid extension and an arginine substitution at position 3. These modifications reduce binding to IGF-binding proteins (IGFBPs) and extend the plasma half-life relative to native IGF-1, making it a widely used tool compound in IGF receptor research.

Research Context

Preclinical investigations have used IGF-1 LR3 in cell-culture and rodent models examining IGF-1 receptor (IGF-1R) signaling, including downstream PI3K/Akt and MAPK pathway activation. Laboratory research has explored the compound in studies of cell proliferation, differentiation, and survival across multiple cell types including myoblasts, osteoblasts, and neuronal cultures. Researchers have also employed IGF-1 LR3 as a reference in structure-activity studies examining how modifications to IGFBP binding alter signaling kinetics relative to native IGF-1. The compound continues to be a fixture in IGF-axis research workflows due to its prolonged activity in cell-culture environments containing serum IGFBPs.

Reconstitution & Storage

  • Recommended reconstitution: 1 mL bacteriostatic water per 1 mg vial
  • Storage: Lyophilized: 2-8°C (refrigerated), long-term -20°C. Reconstituted: 2-8°C, use within 28 days.
  • Stability: Avoid freeze-thaw cycles. Protect from light.

Quality Specifications

Parameter Specification
Purity ≥99% (HPLC)
Identity Confirmed by mass spectrometry
Form Lyophilized powder
Vial size 1 mg
COA Included with order

Research Use Only Disclaimer

This product is sold strictly for laboratory and scientific research purposes. Not for human consumption, ingestion, or administration. Not intended to diagnose, treat, cure, or prevent any disease. Not approved by the FDA for any clinical use.

Reviews

There are no reviews yet.

Be the first to review “IGF-1 LR3 1MG”

Your email address will not be published. Required fields are marked *